RV
Resverlogix Corp.
RVXCF · OTC
$0.07 +16.67% (+$0.01)
1M -12.22%
Market Cap $21.0M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
-
N/A EV/EBITDA N/A
P/S N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
57 /100
Average ROA 127.08%
Asset turnover 0.00x
ROIC 33.65%
Debt
0 /100
High Int. coverage -0.45x
Current ratio 0.04x
Net debt/EBITDA N/A
Stability
81 /100
Stable Beta 1.06x
EPS volatility N/A
Profitable years N/A
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na RVXCF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Donald J. McCaffrey
Employees
19
Headquarters
Calgary
Nadcházející události
12 LIS
Earnings
Upcoming earnings report